For instance, complement overactivation and consumption [3], plasma tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1) [4] and ACE2 activity [5] have recently been tested as new predictors of COVID-19 severity and outcome. This evidence concerns the gene PLAT and COVID-19.